Autoimmune attacks may engage, as dominant effectors, CD8+ T cells (e.g. T1D, vitiligo, AA (6, 92, 93)), CD4+ T cells (e.g. MS, SLE, RA, IBD, EAE, autoimmune thyroid diseases, psoriasis (94)), NK cells (e.g. AA, SLE, RA, MS, psoriasis, T1D (95, 96)) or autoantibodies (e.g. SLE, T1D, psoriasis, Grave’s disease, IBD, MS (97)). This evidence concerns the gene CD4 and rheumatoid arthritis.